HealthQuill Health
Health Medical Pharma

New portable handheld device delivers blood test results in an hour

HQ Team October 22, 2024: A new handheld device can isolate biomarkers for different diseases using sound waves from a single drop of.

Read More
deafness
Drugs Health Medical

Hearing aids can delay onset, progression of Parkinson’s disease

HQ Team October 22, 2024: Hearing aids have emerged as a potentially significant factor in delaying the onset and progression of Parkinson’s disease.

Read More
Danish pharmaceutical company, Novo Nordisk’s oral semaglutide drug to treat type 2 diabetes helped reduce heart diseases by 14% compared to a dummy medicine in a trial, according to a statement.
Drugs Health Pharma

Novo’s type 2 oral diabetic drug cuts heart diseases by 14% in a trial

Danish pharmaceutical company, Novo Nordisk’s oral semaglutide drug to treat type 2 diabetes helped reduce heart diseases by 14% compared to a dummy.

Read More
Egypt gets WHO certification for being a malaria-free country
Drugs Health Pharma

Egypt gets WHO certification for being a malaria-free country

Malaria, which plagued the ancient pharaohs, has been eliminated in Egypt, according to a World Health Organization-certificate, — the third such in in.

Read More
Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.
Drugs Health Pharma

Astellas Pharma gets US regulator’s nod for its gastric cancer drug 

Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.

Read More
Gilead Sciences, Inc. has withdrawn its bladder cancer drug from the US market and stopped its confirmatory clinical trial after it failed to extend the lives of patients who had undergone prior treatments.
Drugs Health Pharma

Gilead’s end-stage confirmatory trials of bladder cancer drug fail

Gilead Sciences, Inc. has withdrawn its bladder cancer drug from the US market and stopped its confirmatory clinical trial after it failed to.

Read More
In a small region in India’s technology capital of Bengaluru, social activists, despite initial hesitation from its urban poor, walked into Anjanapura and completed one of the country’s first short-term engagements to impart the skills to fight climate change.
Climate Health Pharma Research

A social project to fight climate change in India begins to yield results

In a small region in India’s technology capital of Bengaluru, social activists, despite initial hesitation from its urban poor, walked into Anjanapura and.

Read More
Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a secondary goal of a ‘high’ viral suppression rate in adults.
Drugs Health Pharma

Gilead, Merck’s HIV experimental drug scores ‘high’ on viral suppression

Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a.

Read More
As the number of satellites skyrockets, scientists have called for a legally-binding global treaty to ensure the safety of Earth's orbit from space debris, which puts the planet and people at risk.
Climate Health Pharma

Spraying diamond dust in atmosphere can stem global warming: Study

HQ Team  October 18, 2024: As global greenhouse gas emissions continue to rise there is an urgency to find effective climate intervention solutions..

Read More
Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the French company will invest 300 million euros for a 16% equity.
Drugs Health Pharma

Sanofi to invest $324m in entity with Orano Med for radioligand therapy

Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the.

Read More